VinUni Banner
Home Nguyen Van Dinh, PhD, MD
Nguyen Van Dinh, PhD, MD

Nguyen Van Dinh, PhD, MD

Director Head of Allergy/Autoimmunology

Associate Professor

Biography

Assoc. Prof. Nguyen Van Dinh has over 15 years of experience in Allergy, Clinical Immunology, and medical education. He graduated the Degree of Medical doctor at Hanoi Medical University (HMU) in 2007, then he entered the residency program in Allergy and Clinical Immunology in 2011 with excellent standings. Awarded an Australia Awards Scholarship, he earned his PhD in Medicine at the University of Sydney in 2018. Dr. Dinh has held clinical placements at major teaching hospitals in Australia and the U.S. and completed a Health Professional Education program at the University of Pennsylvania in 2023.
Currently, he serves as Director of the Vinmec – VinUni Institute of Immunology and the Center of Excellence in Allergy and Clinical Immunology at Vinmec Times City. He is also affiliated with VinUniversity and Penn State College of Medicine. Professor Dinh has successfully supervised six master’s students, eight VinUniversity resident physicians, and one PhD candidate. He currently supervises five doctoral candidates at universities in Vietnam and internationally. In addition, he holds honorary and adjunct clinical associate professorship appointments at the Penn State College of Medicine and the University of Sydney.

Assoc. Prof. Nguyen’s research focuses on pharmacogenomics in drug hypersensitivity, with notable contributions to HLA associations with severe cutaneous adverse drug reactions (SCARs). He has published one edited book, five book chapters, 34 papers in Vietnamese journals, and 31 ISI/SCOPUS-indexed articles, garnering over 700 citations and an H-index of 12. He is an active reviewer for high-impact journals such as Allergy Journal, The Pharmacogenomics Journal and principal investigator on projects in pharmacogenomics, immunotherapy, hereditary angioedema, and atopic dermatitis. He is an active member of several leading international professional societies, including AAAAI, EAACI, WAO và APAACI. He also contributes to international guideline development and expert committees, including the WAO Cutaneous Allergy Working Group and the APAACI Drug Hypersensitivity Committee.

  1. Machine learning-based model for prediction of carbamazepine- and allopurinol-induced severe cutaneous adverse reactions in Vietnamese. World Allergy Organization Journal. 2026. https://doi.org/10.1016/j.waojou.2026.101408  
  2. Allergen Sensitization in Atopic Dermatitis: Distinction from Controls and Prediction of Respiratory Allergies. International Archives of Allergy and Immunology. 2026. https://doi.org/10.1159/000551372  
  3. Overcome Daratumumab’ severe reaction with desensitization in relapsed multiple myeloma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2025. https://doi.org/10.1177/10781552251356918  
  4. Exploring the Anti-Inflammatory Potential of Isoembigenin: A Flavonoid Glycoside from Piper aduncum L. – A Case Exploration through In Vitro, In Vivo, and In Silico Models. Korean Society for Microbiology and Biotechnology. 2025. https://doi.org/10.4014/jmb.2505.05023  
  5. Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do’s, don’t and maybe’s. World Allergy Organization Journal. 2025. https://doi.org/10.1016/j.waojou.2025.101068  
  6. Chronic urticaria in the real-life clinical practice setting followed by UCARE criteria at a private tertiary teaching hospital in Vietnam. Journal of Allergy and Clinical Immunology. 2025. https://doi.org/10.1016/j.jaci.2024.12.693  
  7. Measuring exhaled nitric oxide in COPD: from theoretical consideration to practical views. Expert Review of Respiratory Medicine. 2024. https://doi.org/10.1080/17476348.2024.2433537  
  8. COVID-19 and severe cutaneous allergic reactions to sulfonamides. Allergy and Asthma Proceedings. 2024. https://doi.org/10.2500/aap.2024.45.240086  
  9. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus. Journal of Allergy and Clinical Immunology. 2024. https://doi.org/10.1016/j.jaci.2024.03.024  
  10. Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria. The World Allergy Organization journal. 2024. https://doi.org/10.1016/j.waojou.2023.100858  
  11. A novel nested allele-specific PCR protocol for the detection of the HLA-A*33:03, a SCAR-associated allele, in Vietnamese people. Asian Pacific Journal of Allergy and Immunology. 2024. https://doi.org/10.12932/AP-201120-1000  
  12. Overlapping Stevens-Johnson Syndrome and DRESS Syndrome Caused by Phenobarbital: A Vietnamese Case Report. Global pediatric health. 2023. https://doi.org/10.1177/2333794X231216556  
  13. Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam. Pharmacogenomics. 2023. https://doi.org/10.2217/pgs-2023-0095  
  14. Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey. The Journal of Allergy and Clinical Immunology: In Practice. 2023. https://doi.org/10.1016/j.jaip.2022.12.021  
  15. Thyroid disease post-COVID-19 infection: Report of a case with new-onset autoimmune thyroid disease. Asia Pacific Allergy. 2023. https://doi.org/10.5415/apallergy.0000000000000023  
  16. Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer. Asia Pacific Allergy. 2023. https://doi.org/10.5415/apallergy.0000000000000131  
  17. Stiff Person Syndrome: A Case Report with Sudden Onset and Coexistence of Sero-Positive Antibodies to Glutamic Acid Decarboxylase and Anti-SOX1 Antibodies. Case Reports in Neurology. 2022. https://doi.org/10.1159/000523988  
  18. Allopurinol-Induced Severe Cutaneous Adverse Reactions in Vietnamese: The Role of HLA Alleles and Other Risk Factors. Pharmacogenomics. 2022. https://doi.org/10.2217/pgs-2021-0156  
  19. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update. World Allergy Organization Journal. 2022. https://doi.org/10.1016/j.waojou.2022.100627  
  20. Autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency: An adjunctive role for omalizumab. Journal of Cutaneous Immunology and Allergy. 2022. https://doi.org/10.1002/cia2.12273  
  21. The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update. Allergy. 2022. https://doi.org/10.1111/all.15214  
  22. The utility of surrogate markers in predicting HLA alleles associated with adverse drug reactions in Vietnamese. Asian Pacific Journal of Allergy and Immunology. 2022. https://doi.org/10.12932/AP-170219-0493  
  23. Utility of skin testing in assessment of post-AZD1222 vaccine (AstraZeneca) allergic reactions: case series in Vietnam. Asia Pacific Allergy. 2021. https://doi.org/10.5415/apallergy.2021.11.e40  
  24. A Novel Allele-Specific PCR Protocol for the Detection of the HLA-C*03:02 Allele, a Pharmacogenetic Marker, in Vietnamese Kinh People. The Application of Clinical Genetics. 2021. https://doi.org/10.2147/TACG.S278652  
  25. Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions. Pharmacogenomics and Personalized Medicine. 2021. https://doi.org/10.2147/PGPM.S290781  
  26. Genetic Susceptibilities and Prediction Modeling of Carbamazepine and Allopurinol-Induced Severe Cutaneous Adverse Reactions in Vietnamese. Pharmacogenomics. 2021. https://doi.org/10.2217/pgs-2019-0146  
  27. Gene Expression Profiling in Allopurinol-Induced Severe Cutaneous Adverse Reactions in Vietnamese. Pharmacogenomics. 2020. https://doi.org/10.2217/pgs-2020-0014  
  28. Successful management of severe diabetic ketoacidosis in a patient with type 2 diabetes with insulin allergy: a case report. BMC Endocrine Disorders. 2019. https://doi.org/10.1186/s12902-019-0451-7  
  29. Drug-induced severe cutaneous adverse reactions: Determine the cause and prevention. Annals of Allergy, Asthma & Immunology. 2019. https://doi.org/10.1016/j.anai.2019.08.004  
  30. Human leukocyte antigen-associated severe cutaneous adverse drug reactions: from bedside to bench and beyond. Asia Pacific Allergy. 2019. https://doi.org/10.5415/apallergy.2019.9.e20  
  31. Developing pharmacogenetic screening methods for an emergent country: Vietnam. World Allergy Organization Journal. 2019. https://doi.org/10.1016/j.waojou.2019.100037  
  32. Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B*58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions. Allergy, Asthma & Immunology Research. 2017. https://doi.org/10.4168/aair.2017.9.1.79  
  33. A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions. HLA. 2017. https://doi.org/10.1111/tan.13143  
  34. Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine – Induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in individuals of Asian ancestry. Human Immunology. 2016. https://doi.org/10.1016/j.humimm.2016.08.010  
  35. Validation of a Rapid Test for HLA-B*58:01/57:01 Allele Screening to Detect Individuals at Risk for Drug-Induced Hypersensitivity. Pharmacogenomics. 2016. https://doi.org/10.2217/pgs.15.185  
  36. HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese. Asia Pacific allergy. 2015. https://doi.org/10.5415/apallergy.2015.5.2.68  
  37. Description of 3 Cases in Vietnam of Aspirin Desensitization in Patients With Coronary Artery Disease and Coexisting Aspirin Hypersensitivity. World Allergy Organization Journal. 2012. https://doi.org/10.1097/WOX.0b013e3182718327  

1. The Best Paper Award at the Asia Pacific Allergy and Clinical Immunology Conference, 2013, Taiwan.

2. Chair’s Man Award from the Hoc Mai Foundation, University of Sydney, for contributions to research and scientific development.

3. Third Prize “Đặng Văn Ngữ” of Hanoi Medical University, 2017, for faculty members with publications in high-impact journals.

4. Best Paper of the Year Award, Asia Pacific Allergy Journal, 2018.

5. Favorite Visiting Lecturer Award, Hanoi Medical University, 2019.

6. APSR Clinical Allergy & Immunology Assembly Education Award at the 24th Congress of the Asian Pacific Society of Respirology, 2019.

7. Internal Medicine Residency Program Excellent Teacher Award, Academic Year 2020–2021.

8. Best Presenter Award at the Annual Scientific Conference of the Vietnam Rheumatology Association, May 20, 2023.

9. Most Downloaded Article Award for the 12 months following publication in Allergy journal (January 1, 2022 – December 31, 2022).

10. Certification of the Allergy – Clinical Immunology Center achieving ADCARE 2023, UCARE 2024, and WAO 2025.

11. Certification of appointment as Associate Professor, 2024.